Jump to content

Alkem Laboratories: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
No edit summary
No edit summary
Line 18: Line 18:
| products = [[Pharmaceutical]]s, [[generic drug]]s, [[over-the-counter drug]]s, [[vaccine]]s, [[Medical diagnosis|diagnostics]], [[contact lens]]es, [[Veterinary medicine|animal health]]
| products = [[Pharmaceutical]]s, [[generic drug]]s, [[over-the-counter drug]]s, [[vaccine]]s, [[Medical diagnosis|diagnostics]], [[contact lens]]es, [[Veterinary medicine|animal health]]
| services =
| services =
| revenue = {{increase}}{{INRConvert|10634.1|c}} (2022)<ref name=finance>{{cite web|url=https://www.alkemlabs.com/pdf/annual-report/Annual_Report_2019-20-2.pdf|title=Alkem Laboratories Limited Annual Report 2020|publisher=Alkem Laboratories Limited|accessdate=2 July 2020}}</ref>
| revenue = {{increase}} {{INRConvert|10634|c}} (2022)<ref name=finance>{{cite web|url=https://www.alkemlabs.com/pdf/annual-report/Annual_Report_2019-20-2.pdf|title=Alkem Laboratories Limited Annual Report 2020|publisher=Alkem Laboratories Limited|accessdate=2 July 2020}}</ref>
| operating_income = {{increase}}{{INRConvert|1911.6|c}} (2022)<ref name=finance/>
| operating_income = {{increase}} {{INRConvert|2052|c}} (2022)<ref name=finance/>
| net_income = {{increase}}{{INRConvert|1680.3|c}} (2022)<ref name=finance/>
| net_income = {{increase}} {{INRConvert|1645|c}} (2022)<ref name=finance/>
| assets = {{increase}}{{INRConvert|14069.1|c}} (2022)<ref name=finance/>
| assets = {{increase}} {{INRConvert|14069|c}} (2022)<ref name=finance/>
| equity = {{increase}}{{INRConvert|8637.9|c}} (2022)<ref name=finance/>
| equity = {{increase}} {{INRConvert|8637|c}} (2022)<ref name=finance/>
| num_employees = 15,357 (2021)<ref name=finance/>
| num_employees = 15,357 (2021)<ref name=finance/>
| owner =
| owner =

Revision as of 00:45, 29 May 2024

Alkem Laboratories Limited
Company typePublic
BSE: 539523
NSE: ALKEM
IndustryPharmaceuticals
Founded1973
FounderSamprada Singh[1]
Headquarters
Mumbai, Maharashtra
,
India
ProductsPharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
RevenueIncrease ₹10,634 crore (US$1.3 billion) (2022)[2]
Increase ₹2,052 crore (US$250 million) (2022)[2]
Increase ₹1,645 crore (US$200 million) (2022)[2]
Total assetsIncrease ₹14,069 crore (US$1.7 billion) (2022)[2]
Total equityIncrease ₹8,637 crore (US$1.0 billion) (2022)[2]
Number of employees
15,357 (2021)[2]
SubsidiariesGalpha Laboratories
Websitewww.alkemlabs.com

Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India and globally.

Company

Alkem set up its research and development facility for ANDA development at Taloja in 2003.[3] In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India.[4] In 2014 Clavam another drug from Alkem crossed 2,000 million mark in terms of domestic sales in India.

In 2007 the company filed its first ANDA for drug Amlodipine which was approved in 2009.[3] Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are US FDA, TGA, UK MHRA approved.

Acquisitions

Alkem has 300 manufacturing facilities: 19 in India and 2 in the US.[5] These 2 facilities in the US were acquired in 2012 and 2013 respectively. In 2014, Alkem acquired the "Clindac-A" brand in India from Galderma S.A. In 2015, Alkem acquired a formulation manufacturing facility in the US.[6]

Governance and administration

Samprada Singh was the founder and chairman emeritus of the company, he led and shaped Alkem what it is today, he had a B.Com. degree from Patna University. He was the 42nd richest person in India and a billionaire.[7] His brother, Basudeo Narayan Singh,[8] was also the co-founder of the company. Samprada Singh died on 27 July 2019 at the age of 94 years after a brief illness in Mumbai.[9]

Position Name
Founder Chairman Emeritus Mr. Samprada Singh
Executive Chairman Mr. Basudeo Narayan Singh
Joint Managing Director Ms. Dhananjay Kumar Singh
Joint Managing Director Mr. Sandeep Singh
Independent Director Dr. Dheeraj Sharma
Independent Director Mr. A.K. Purwar
Independent Director Mr. N. K. Aneja
Independent Director Mr. R. L. Shenoy
Independent Director Ms. Sangeeta Singh
Independent Director Ms. Sudha Ravi [10]

References

  1. ^ "List of Top Largest Pharmaceutical Companies in India [Updated 2022-2023]". Edudwar. 6 May 2022. Retrieved 31 May 2022.
  2. ^ a b c d e f "Alkem Laboratories Limited Annual Report 2020" (PDF). Alkem Laboratories Limited. Retrieved 2 July 2020.
  3. ^ a b "Alkem Laboratories Ltd. (ALKEM) - Company History". Business Standard India. Retrieved 31 May 2022.
  4. ^ "Alkem Laboratories History | Alkem Laboratories Information". The Economic Times. Retrieved 31 May 2022.
  5. ^ "List of Top Largest Pharmaceutical Companies in India [Updated 2022-2023]". Edudwar. 6 May 2022. Retrieved 31 May 2022.
  6. ^ Balakrishnan, Reghu (25 November 2015). "Alkem plans to double US revenue by 2020, launch IPO in December". mint. Retrieved 31 May 2022.
  7. ^ "Samprada Singh & family". Forbes.
  8. ^ "Basudeo Singh". Bloomberg.
  9. ^ "Alkem Labs Founder Samprada Singh passes away at the age of 92 years". Medical Dialogues. 27 July 2019.
  10. ^ "Board of Directors". Alkem.
Stub icon 1 Stub icon 2

This article about an Indian company is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Alkem_Laboratories&oldid=1226176026"